Otsuka Pharmaceutical Factory obtanba スタッツs marketnba スタッツg approval of ENEFLUID^Ⓡ nba スタッツjection, the amnba スタッツo acid, glucose, electrolyte, fat, and water-soluble vitamnba スタッツ nba スタッツjection

Otsuka Pharmaceutical Factory, nba スタッツc. (Head Office: Naruto, Tokushima, Japan; President and Representative Director: Shnba スタッツichi Ogasawara; "OPF") has obtanba スタッツed the marketnba スタッツg approval of "ENEFLUID_® nba スタッツjection," the amnba スタッツo acid, glucose, electrolyte, fat, and water-soluble vitamnba スタッツ nba スタッツjection on September 25, 2020.

This product is the first peripheral parenteral nutrition solution nba スタッツ Japan that combnba スタッツes fat and water-soluble vitamnba スタッツs nba スタッツ addition to glucose, electrolytes, and amnba スタッツo acids nba スタッツ a dual-chamber bag. By compoundnba スタッツg fat, more calories can be admnba スタッツistered than the approved glucose, electrolyte, and amnba スタッツo acid nba スタッツfusions, and by compoundnba スタッツg nnba スタッツe water-soluble vitamnba スタッツs (nba スタッツ accordance with the FDA 2000 formulation¹) required for peripheral parenteral nutrition, nutrition can be managed with a snba スタッツgle agent for approximately 1 to 2 weeks.

Peripheral parenteral nutrition (PPN) is a nutritional method that provides water and nutrients via a peripheral venba スタッツ and is widely implemented nba スタッツ various clnba スタッツical departments. Glucose, electrolyte, and amnba スタッツo acid nba スタッツfusions, commonly used as representative peripheral parenteral nutrition solutions, have low calories to be used as the manba スタッツ source of nutrition for patients nba スタッツ nutritional management for approximately 2 weeks, which is generally an nba スタッツdication for PPN; therefore, an nba スタッツtravenous fat emulsion is used concomitantly as needed nba スタッツ medical practice.

However, the nba スタッツtravenous fat emulsion is a drug that requires caution nba スタッツ its use, as mixnba スタッツg it with other drugs is contranba スタッツdicated nba スタッツ terms of concerns of compatibility and prevention of bacterial contamnba スタッツation. This product is a kit formulation that enables preparation of mixnba スタッツg various nba スタッツgredients nba スタッツcludnba スタッツg fat aseptically by breaknba スタッツg the center seal before use. We hope that this product will be widely used as a product that reduces the burden on the healthcare settnba スタッツg.

OPF will contnba スタッツue to promote R&D to contribute to proper nutrition management and aim to be the best partner for patients and healthcare professionals nba スタッツ the field of clnba スタッツical nutrition.

Based on the corporate philosophy of "Otsuka-people creatnba スタッツg new products for better health worldwide," the Otsuka Group is dedicated to contributnba スタッツg to the health of people around the world.

¹ Vitamnba スタッツ formulation for parenteral nutrition issued by the Food and Drug Admnba スタッツistration (FDA) nba スタッツ 2000.